Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
- Authors
- Kim, Yong-Ku; Jeon, Sang Won
- Issue Date
- 2018
- Publisher
- BENTHAM SCIENCE PUBL LTD
- Keywords
- Anxiety; kynurenine; tryptophan catabolites; serotonin; psychoimmunology; neuroinflammation
- Citation
- CURRENT NEUROPHARMACOLOGY, v.16, no.5, pp.574 - 582
- Indexed
- SCIE
SCOPUS
- Journal Title
- CURRENT NEUROPHARMACOLOGY
- Volume
- 16
- Number
- 5
- Start Page
- 574
- End Page
- 582
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/80918
- DOI
- 10.2174/1570159X15666170913110426
- ISSN
- 1570-159X
- Abstract
- Background: Recently, neuroinflammation and the immune-kynurenine pathway have received increased attention in the psychoimmunology field of major depressive disorder (MDD), while studies related to anxiety disorders have been very limited. Objective: This study reviewed possible mechanisms by which stress or inflammation modulate anxiety through tryptophan metabolism and the kynurenine pathway. Methods: Relevant literature was identified through a search of MEDLINE via PubMed. Results: Accumulating evidence has indicated the modulatory effects of the immune-kynurenine pathway on anxiety. The tryptophan catabolites (TRYCATs) in the kynurenine pathway imbalanced by stress or inflammation induce serotonin and melatonin deficiency, making anxiety reactions more sensitive. In addition, TRYCATs cause or sustain anxiety by acting as endogenous anxiogens or anxiolytics, an NMDA agonist or antagonist, or a free radical generator. Conclusion: We hope that our understanding of the psychoimmunological mechanisms of anxiety will be expanded and anxiety-related studies will receive greater attention.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.